Downstream Processing Featured Articles

  1. New Objective And McKinley Scientific Announce A Strategic Co-Marketing Collaboration In High-Performance LC-MS 11/27/2012

    McKinley Scientific, LLC and New Objective, Inc. recently announced that they have entered into a strategic co-marketing and development agreement designed to enable and expand key applications for delivery of high-performance LC-MS systems.

  2. Catalan Researchers Identify A Key Component Of Cell Division 8/21/2012

    A study by the Institute for Research in Biomedicine (IRB Barcelona) and the Center for Genomic Regulation (acronym in Catalan CRG) highlights the protein Nek9 as a decisive factor in cell division, a fundamental process for both the development of an organism and tissue maintenance. 

  3. Galapagos And Roche Conclude Strategic Alliance 3/8/2013

    Galapagos NV (EURONEXT BRUSSELS: GLPG) announced today that it agreed with Roche to end their alliance in fibrosis.

  4. Frost & Sullivan: Biosimilars Market Expected To Soar 2/14/2013

    Top representatives from the healthcare industry are confirmed to attend the 2nd Biosimilars Congregation which will take place in London on the 19th and 20th of February 2013. Ranjith Gopinathan, Frost & Sullivan Program Manager for Life Sciences, Europe Practice is set to participate to the event’s Keynote Panel Discussion focusing on challenges and opportunities in the global biosimilars market.

  5. Successful Immunization And Safety Documented In Nasal Administration Study Of The HIV Vaccine Vacc-4x Together With Endocine 5/10/2012

    Bionor Pharma ASA (OSLO: BIONOR), Eurocine Vaccines AB and Oslo University Hospital today announced that vaccine related immune responses are documented in patients given active vaccine in a nasal immunization study, combining Bionor Pharma's Vacc-4x and Eurocine Vaccines' adjuvant Endocine.

  6. The Real Threat To Biopharma Supply Chains: Bioprocessing Materials 5/12/2020

    The COVID-19 induced risk to biopharma is not a shortage of pharmaceutical ingredients. It’s the constricting supply of consumable materials and equipment necessary to produce therapies from them. Mike Piccarreta, Partner at Kearney, offers an outlook and practical advice on supply stabilization in this BioProcess Online exclusive. 

  7. Roche Invests In Stratos Genomics For Further Development Of The 'Sequencing By Expansion' (SBX) Method Applied To Single Molecule Nanopore Sequencing 6/26/2014

    Roche announced recently, it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using protein nanopores.

  8. Designer Bacteria May Lead To Better Vaccines 1/15/2013

    Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

  9. Synergies For Equipping The Single-Use Bioproduction Suite 10/7/2006
    The growth of biopharmaceuticals entering the market has served to change the appearance of the bioproduction suite
  10. Thermo Fisher Scientific Introduces Data System To Unite Chromatography And Mass Spectrometry 3/18/2013

    Thermo Fisher Scientific Inc., the world leader in serving science, recently introduced the next generation of its gold-standard Chromeleon chromatography data system (CDS), which now supports mass spectrometry along with mainstream front-end separation techniques in the same software package.